CLINICAL_TRIALS
trial_result
· 2024-07-30
Clinical Trial Update: Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil [Phase 3]
Summary
Phase 3 results update on the safety and pharmacology of dry powder inhaled treprostinil for pulmonary arterial hypertension.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Liquidia Technologies, Inc. | Conditions: Primary Pulmonary Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2024-07-30